New York City - American multinational pharmaceutical and biotechnology corporation Pfizer has announced that it is seeking FDA approval of a powerful new amulet form of its popular antibiotic Zithromax.
Subject #17, shown here wearing a prototype Zithromax amulet during a recent study in patients who think they might be coming down with a cold |
"Zithromax is a name that prescribers and patients have learned to trust since it first hit the market in 1991," Pfizer CEO Albert Bourla explained. "But we are always seeking to develop new and innovative ways to improve access and adherence to our lifesaving and life changing pharmaceuticals."
If approved, patients prescribed a Zithromax amulet (marketed as Z-Pec) will be advised to begin wearing the provided necklace with the drug-infused pendant hanging against the anterior chest wall at the first sign of illness. According to Bourla, the official indication will upper respiratory infections, but there will likely be additional benefits. "We have studied the Z-Pec in thousands of people in several phase 3 trials, and it is every bit as effective as oral Zithromax when it comes to the treatment of cough, runny nose, and sore throat. And not a single subject was attacked by a tiger at any point during these studies. Not even once."
No comments:
Post a Comment